Friday, July 10, 2026

Drug profile · INN

bisoprolol

bisoprolol (BISOPROLOL GENERICHEALTH) is a beta-1 adrenergic receptor antagonist. Associated with Alphapharm Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 14
News articles 0
Drug details — bisoprolol

Quick answer

bisoprolol (BISOPROLOL GENERICHEALTH) is a beta-1 adrenergic receptor antagonist. Associated with Alphapharm Pty Ltd.

Key facts

INN bisoprolol
Brand BISOPROLOL GENERICHEALTH
Mechanism Beta-1 adrenergic receptor antagonist

Mechanism of action

Beta-1 adrenergic receptor antagonist

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. Bisoprolol Fumarate Phase 3 · Chinese Academy of · Duchenne Muscular Dystrophy
  2. D3250C00101 Phase 3 · AstraZeneca · Eosinophilic Asthma
  3. D5982C00006 Phase 3 · AstraZeneca · Inadequately Controlled Asthma
  4. D5982C00007 Phase 3 · AstraZeneca · Severe and inadequately controlled asthma
  5. D5982C00008 Phase 3 · AstraZeneca · Severe and inadequately controlled asthma
  6. Symbicort Turbuhaler Phase 3 · AstraZeneca · Asthma
  7. Vebicorvir (VBR) Phase 1 · ASSEMBLY BIOSCIENCES · Chronic Hepatitis B
  8. APHP180618 Approved · PARItec · Asymptomatic Patients with frequent PVCs and normal LVEF

Frequently asked questions

What is bisoprolol?

bisoprolol (BISOPROLOL GENERICHEALTH) is a beta-1 adrenergic receptor antagonist. Associated with Alphapharm Pty Ltd.

What is the brand name for bisoprolol?

BISOPROLOL GENERICHEALTH is a marketed brand name for bisoprolol. Check FDA Drugs@FDA for the current US label holder and prescribing information.